AU2001234523A1 - Methods for detecting neurological disorders - Google Patents

Methods for detecting neurological disorders

Info

Publication number
AU2001234523A1
AU2001234523A1 AU2001234523A AU3452301A AU2001234523A1 AU 2001234523 A1 AU2001234523 A1 AU 2001234523A1 AU 2001234523 A AU2001234523 A AU 2001234523A AU 3452301 A AU3452301 A AU 3452301A AU 2001234523 A1 AU2001234523 A1 AU 2001234523A1
Authority
AU
Australia
Prior art keywords
methods
neurological disorders
detecting neurological
detecting
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001234523A
Inventor
Paul O Sheppard
Theodore E. Whitmore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of AU2001234523A1 publication Critical patent/AU2001234523A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4709Amyloid plaque core protein
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2814Dementia; Cognitive disorders
    • G01N2800/2821Alzheimer

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001234523A 2000-04-10 2001-01-23 Methods for detecting neurological disorders Abandoned AU2001234523A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54635800A 2000-04-10 2000-04-10
US09/546,358 2000-04-10
PCT/US2001/002177 WO2001077393A2 (en) 2000-04-10 2001-01-23 Methods for detecting neurological disorders

Publications (1)

Publication Number Publication Date
AU2001234523A1 true AU2001234523A1 (en) 2001-10-23

Family

ID=24180067

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001234523A Abandoned AU2001234523A1 (en) 2000-04-10 2001-01-23 Methods for detecting neurological disorders

Country Status (2)

Country Link
AU (1) AU2001234523A1 (en)
WO (1) WO2001077393A2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3863499A (en) * 1998-04-21 1999-11-08 Zymogenetics Inc. Soluble protein ztmpo-1
US6372889B1 (en) * 1998-04-21 2002-04-16 Zymogenetics, Inc. Soluble protein ZTMPO-1
CA2373191A1 (en) * 1999-05-14 2000-11-23 Incyte Genomics, Inc. Full-length molecules expressed in human tissues

Also Published As

Publication number Publication date
WO2001077393A2 (en) 2001-10-18
WO2001077393A3 (en) 2002-12-27

Similar Documents

Publication Publication Date Title
AU2001296232A1 (en) Neurological testing apparatus
AU3389701A (en) Method for investigating neurological function
AU2002216195A1 (en) Motorcycle-type vehicle
AU2001267740A1 (en) Separation method
AU2001290685A1 (en) Methods for inhibiting inflammatory disease
AU2001241733A1 (en) Methods for determining single nucleotide variations
AU2002214971A1 (en) Device for determining tread force
AU2001263909A1 (en) Diphenylmethane derivatives
AU2001269769A1 (en) Methods for making bis-heterocyclic alkaloids
AU2002356180A1 (en) Methods for inhibiting angiogenesis
AU2001220281A1 (en) Rollerboard for road-skiing
AU2001240639A1 (en) Supporting device for vehicles
AU2001276898A1 (en) Synthetic peptide for neurological disorders
AU3190899A (en) Methods for detecting neurological disorders
AU2002214487A1 (en) Method for inducing apoptiosis
AU5867901A (en) Method for detecting tumors
AU5414100A (en) Chroman derivatives against neurological disorders
AU2001266915A1 (en) Probes for chondrogenesis
AU2001259161A1 (en) Method for making polyimide
AU2002341044A1 (en) Methods for detecting parkinson's disease
AU2001283197A1 (en) Method for detecting plug wear
AU2001234523A1 (en) Methods for detecting neurological disorders
AU2002220757A1 (en) Method for obtaining azaerythromycin
AU2001217349A1 (en) Apparatus for parking lot
AU2001245781A1 (en) Cd18-binding antibodies inhibit stenosis-related disorders